John Raymond Murphy, Director at Cadrenal Therapeutics, Inc. (CVKD), bought 20,000 shares at $0.70 ($14K) on 2023-10-04, disclosed to the SEC on 2023-10-06.
Open-market purchase of $14k CVKD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.70 | 17,331 | $12K | 86.8% |
| 2 | $0.69 | 2,669 | $2K | 13.2% |
| Total | $0.70 avg | 20,000 | $14K | 100% |
| Filing → |
| ORLY | SELL | 2025-05-20 | $276K | — | Filing → |
| ORLY | SELL | 2024-02-15 | $559K | — | Filing → |
| ORLY | SELL | 2023-11-02 | $465K | — | Filing → |